CORRECTED-US STOCKS-S&P 500, Nasdaq rise as tech stocks gain, oil rebounds
June 23 The S&P 500 and the Nasdaq Composite were higher in late morning trading on Friday as technology shares rose and oil prices rebounded from multi-month lows.
March 23 Aeglea Bio Therapeutics Inc
* Aeglea Biotherapeutics to present topline data from phase 1 trial of AEB1102 for treatment of Arginase I deficiency at 2017 ACMG annual clinical genetics meeting
* Treatment with AEB1102 well tolerated, no related adverse events or clinically significant abnormal laboratory results reported
* Study showed that single, intermittent doses of AEB1102 resulted in reduction of arginine in blood to normal levels Source text for Eikon: Further company coverage:
WASHINGTON, June 23 The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery.